Regulatory
Published the 15 February 2021Invent Medic announces that the company has submitted an application to FDA for 510(k) market registration of the product Efemia bladder support in the United States. Invent Medic expects to be able to present marketing and sales plans for the product in the United...
Regulatory
Published the 11 February 2021The Board of Directors and the President will issue the following financial statements for the 2020 financial year. Unless otherwise specified, all amounts are reported in integers (SEK). Data in parentheses refer to the previous year. CEO Karin Bryder summarizes We...
Regulatory
Published the 14 December 2020Invent Medic announces that the company has signed a distribution agreement with Madrid-based En Suelo Firme, a company specialized in offering pelvic floor health products to Spanish-speaking women in Europe. En Suelo Firme has a strong social media presence, with...
Regulatory
Published the 27 October 2020Solid sales in Sweden and Norway, while other markets are still affected by the corona pandemic FIRST NINE MONTHS (January–September 2020) The company’s sales amounted to 1,161 (248) KSEK. Other operating income amounted to 13 (0) KSEK. Operating costs amounted to...
Regulatory
Published the 22 October 2020Invent Medic announces that the company has appointed EMERGO by UL as its US representative in FDA-related matters, including the company’s upcoming 510(k) application for Efemia bladder support. As previously stated, Invent Medic is planning to submit a so-called...
Regulatory
Published the 4 October 2020Invent Medic Sweden AB announces that its distributor Arteriomed GmbH has received information from The National Association of Health Insurance Funds GKV that it will, from October 15 2020, include Invent Medic’s first product Efemia bladder support in the list of...
Regulatory
Published the 14 September 2020Invent Medic announces that the Swedish pharmacy chain Kronans Apotek will include the product Efemia bladder support in its online assortment. Efemia will become available to buy on kronansapotek.se in October 2020. With this agreement, Efemia will soon be available...
Regulatory
Published the 25 August 2020Invent Medic Sweden AB announces that the MAR label in the company’s Q2 report was missing. Invent Medic Sweden AB publishes an updated quarterly report with correction, when the MAR label in the earlier report was missing.
Regulatory
Published the 25 August 2020Continued sales growth despite Covid-19 shutdowns in the UK and Germany FIRST HALF OF THE YEAR (January-June) · The company’s sales amounted to 873 (218) KSEK. · Operating costs amounted to 8,300 (6,333) KSEK. · Result before and after tax amounted to -7,545 (-6,116)...
Regulatory
Published the 3 July 2020Invent Medic announces that the company has signed an agreement with the Swedish online pharmacy Apotea for the inclusion of the product Efemia bladder support in Apotea’s assortment. Efemia will become available to buy on apotea.se during the summer. With this...
